Show Summary Details
Page of

Osteopenia in uremia 

Osteopenia in uremia
Chapter:
Osteopenia in uremia
Author(s):

Ezequiel Bellorin-Font

, Judith Adams

, and John Cunningham

DOI:
10.1093/med/9780199559176.003.014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 August 2020

The progressive loss of kidney function results in a series of disorders of mineral metabolism that ultimately lead to bone alterations, cardiovascular and other soft tissue calcifications. In addition the treatment given to many patients with chronic kidney disease (CKD) may increase the risks of bone and mineral disorders. Recent studies indicate that a strong association exists between alterations of bone and mineral metabolism, fractures, and cardiovascular disease, the leading cause of mortality in patients with CKD.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.